Skip to main content
. 2016 Feb 8;7(11):12704–12717. doi: 10.18632/oncotarget.7260

Figure 3. Kaplan–Meier survival curves for colorectal cancer (stages I-IV) according to the EZH2 expression level.

Figure 3

A. In terms of cancer-specific survival, significantly lower mortality was observed in patients with high EZH2 expression than in those with low EZH2 expression (log-rank test: P = 0.010). B. In terms of cancer-specific survival, significantly lower mortality was observed in patients with high expression (score 3) than in those with low expression (score 0–2) (log-rank test: P = 0.0022).